Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaPhase 2NCT07685717
Pirtobrutinib for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography
265 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Leukemia, lymphoma, and myeloma265 studies
Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaPhase 2NCT07685717
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography
Follicular LymphomaPhase 2NCT06350318
Zanubrutinib, Rituximab
Peripheral T Cell LymphomaPhase 2NCT06630091
Golidocitinib, Cyclophosphamide, Doxorubicin, Vincristine
Hematological MalignanciesPhase 2NCT04634552Papers
Talquetamab
Multiple MyelomaPhase 2NCT07149857
Cilta-cel, Cyclophosphamide, Induction therapy, Fludarabine
Follicular LymphomaPhase 2NCT06563596
Zanubrutinib, Rituximab, Epcoritamab
Recurrent Acute Myeloid LeukemiaPhase 2NCT03629171Papers
Liposome-encapsulated Daunorubicin-Cytarabine, Venetoclax
Large B-cell LymphomaPhase 2NCT06045247
Prednisone, Rituximab, Cyclophosphamide, Vincristine
B-Cell Lymphoblastic LeukemiaPhase 2NCT06144606
Tecartus
B Cell LymphomaPhase 2NCT06213311
Glofitamab, Obinutuzumab, Axi-cel
Relapsed or Refractory Post-Transplant Lymphoproliferative DisorderPhase 1NCT06672705
Epcoritamab for the Treatment of Relapsed or Refractory Post Transplant Lymphoproliferative Disorders
Relapsed/Refractory Acute Myeloid LeukemiaPhase 1NCT03874052Papers
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Multiple MyelomaPhase 2NCT05789303
Belantamab mafodotin, Carfilzomib, Pomalidomide, Dexamethasone
Relapsed Classic Hodgkin LymphomaPhase 2NCT04561206
Brentuximab Vedotin, Nivolumab
Relapsed or Refractory Acute Myeloid LeukemiaPhase 1NCT07661095
CRD3874-SI in People With Leukemia
Recurrent Grade 1 Follicular LymphomaPhase 2NCT06453044
Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Mosunetuzumab
Lymphoma, Non-HodgkinPhase 2NCT02693535Papers
Sunitinib (CLOSED TO ENROLLMENT), Trastuzumab and Pertuzumab (CLOSED TO ENROLLMENT), Vemurafenib and Cobimetinib (CLOSED TO ENROLLMENT), Olaparib (CLOSED TO ENROLLMENT)
Multiple MyelomaPhase 2NCT04661137Papers
Selinexor 60 MG, Selinexor 80 MG, Selinexor 100 MG, Carfilzomib
Multiple Myeloma RefractoryPhase 2NCT07096778
Inobrodib, Pomalidomide, Dexamethasone
Relapsed / Refractory AMLPhase 2NCT07710534
Decitabine-cedazuridine plus venetoclax (DEC-C+VEN), Azacitidine plus venetoclax (AZA+VEN)
Marginal Zone LymphomaPhase 2NCT05296070
Loncastuximab tesirine 150 µg/Kg, Loncastuximab tesirine 75µg/Kg
Mantle Cell LymphomaPhase 1/2NCT06029309
Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma
T-cell Acute Lymphoblastic LeukemiaPhase 2NCT06561074
Decitabine, Venetoclax, Calaspargase pegol-mknl
Hodgkin LymphomaPhase 2NCT05615636Papers
Mosunetuzumab, Polatuzumab vedotin, Tafasitamab, Lenalidomide